Get started

Pfizer (Spain)

Homepage: pfizer.com
Parent institution: Pfizer (United States)
ROR: 03x2xt559
OpenAlex ID: I4210138890
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
2022 · Steven R. Ytterberg, Deepak L. Bhatt, et al. · New England Journal of Medicine · 1,819
PDF
Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool
2010 · Javier Garcia-Campayo, Enric Zamorano, et al. · Health and Quality of Life Outcomes · 668
PDF
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results
2023 · Alexander M. Lesokhin, Michael H. Tomasson, et al. · Nature Medicine · 652
PDF
Treatment of restless legs syndrome with gabapentin
2002 · D. Garcia-Borreguero, O. Larrosa, et al. · Neurology · 405
The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing
2020 · Katie Palmer, Alessandro Monaco, et al. · Aging Clinical and Experimental Research · 360
PDF
Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care
2010 · Miguel A. Ruiz, Enric Zamorano, et al. · Journal of Affective Disorders · 297
Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy
1997 · J. Nolla-Salas, A. Sitges-Serra, et al. · Intensive Care Medicine · 263
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance
2022 · Christina Charles-Schoeman, Maya H Buch, et al. · Annals of the Rheumatic Diseases · 221
PDF
Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population
2004 · Luis A. García Rodríguez, Cristina Varas-Lorenzo, et al. · Circulation · 221
Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component
2007 · Concepcion Perez, Rafael Galvez, et al. · Health and Quality of Life Outcomes · 219
PDF
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
2009 · C Alfaro, N Suarez, et al. · British Journal of Cancer · 215
PDF
Frequency of Sexual Dysfunction and Other Reproductive Side-effects in Patients with Schizophrenia Treated with Risperidone, Olanzapine, Quetiapine, or Haloperidol: The Results of the EIRE Study
2003 · J. BOBES, M. P. GARC A-PORTILLA, et al. · Journal of Sex & Marital Therapy · 213
PDF
The dual kinase complex FAK-Src as a promising therapeutic target in cancer
2010 · Victoria Bolós · OncoTargets and Therapy · 202
PDF
Carcass and meat quality characteristics of immunocastrated male, surgically castrated male, entire male and female pigs
2010 · Marina Gispert, M. Àngels Oliver, et al. · Meat Science · 201
Non‐Steroidal Antiinflammatory Drugs and the Risk of Acute Myocardial Infarction
2006 · Sonia Hernández‐Díaz, Cristina Varas‐Lorenzo, et al. · Basic & Clinical Pharmacology & Toxicology · 201
PDF
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study
2006 · J BOBES, C ARANGO, et al. · Schizophrenia Research · 195
Male Erectile Dysfunction and Health-Related Quality of Life
2003 · J.J. Sánchez-Cruz, A. Cabrera-León, et al. · European Urology · 191
Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort
2010 · Julio Bobes, Celso Arango, et al. · Schizophrenia Research · 181
Development and Validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED-Q)©
2008 · Miguel A. Ruiz, Antonio Pardo, et al. · Value in Health · 178
Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study
2006 · Pilar Carrasco Garrido, Javier de Miguel Díez, et al. · Health and Quality of Life Outcomes · 174
PDF
Effects of Atorvastatin on Vitamin D Levels in Patients With Acute Ischemic Heart Disease
2007 · José L. Pérez-Castrillón, Gemma Vega, et al. · The American Journal of Cardiology · 172
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial
2022 · Tim H. Brümmendorf, Jorge E. Cortes, et al. · Leukemia · 145
PDF
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry
2021 · Joel M. Kremer, Clifton O. Bingham, et al. · ACR Open Rheumatology · 143
PDF
Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study
2003 · J. Bobes, J. Rejas, et al. · Schizophrenia Research · 140
Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study
2009 · Antoni Sicras-Mainar, Javier Rejas, et al. · Arthritis Research & Therapy · 137
PDF
Works count: 1,193
Citation count: 41,360
Year
Topic
Type